BrainKey
Private Company
Total funding raised: $18.2M
Overview
BrainKey is a private, pre-revenue AI neuroimaging diagnostics company building a software platform to extract actionable insights from brain MRI scans. Founded by neuroscientist Dr. Owen Philips and backed by Y Combinator, the company leverages advanced machine learning to identify and visualize key biomarkers, aiming to make complex anatomical data accessible for physicians and patients. Its mission is to provide tools for the early assessment of brain health, targeting the massive unmet need in neurological and psychiatric care, particularly in the context of rising dementia prevalence. The company is in the development and early commercial validation stage, offering scans and analysis directly or through partnerships.
Technology Platform
AI/ML platform for quantitative analysis of brain MRI scans, generating biomarkers and interactive 3D visualizations of individual brain anatomy.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
BrainKey competes in the growing AI neuroimaging market against both large medical imaging corporations (GE, Siemens) integrating AI and a multitude of startups (e.g., Viz.ai, Cortechs.ai, Icometrix). Its differentiation lies in its focus on individual-level analysis, strong neuroscience research pedigree, and emphasis on patient-facing visualizations.